Though FDA made its position on CBD clearer at the end of 2019, technically all of FDA’s enforcement actions so far have qualified as unofficial agency actions.

With a market estimated to grow more than 260% to a dizzying $1.25 billion over the next four years, it appears that the demand for cannabidiol, more commonly known as CBD, is expected to continue to grow. All of this growth is still expected despite the actions by the Food and Drug Administration (FDA).

In November 2019, FDA issued Warning Letters to more than a dozen companies saying they had violated the Federal Food, Drug, and Cosmetic Act for selling consumer products with CBD. FDA stated that these products could not be marketed because they made unlawful drug claims for their products and that the use of CBD in these products was inappropriate. FDA’s currently stated policy is that CBD cannot be used as ingredients in food and dietary supplements without new FDA regulations allowing its use. Furthermore, FDA stated that it had safety concerns regarding the use of CBD due to potential side effects associated with the ingredient.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.